Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
I166771-5mg | 5mg | In stock | $103.90 | |
I166771-10mg | 10mg | In stock | $153.90 | |
I166771-25mg | 25mg | In stock | $346.90 | |
I166771-50mg | 50mg | In stock | $450.90 | |
I166771-100mg | 100mg | In stock | $741.90 | |
I166771-250mg | 250mg | In stock | $1,669.90 |
Potent and high affinity BRD inhibitor; anti-inflammatory.
Synonyms | 1260907-17-2|molibresib|I-BET-762|GSK 525762A|GSK525762A|I-BET 762|GSK525762|GSK-525762|I-BET762|Bet inhibitor GSK525762|GSK-525762A|UNII-5QIO6SRZ2R|5QIO6SRZ2R|(S)-2-(6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-y |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Potent and high affinity BRD inhibitor (IC50= 32.5 - 42.5 nM; Kd= 50.5 - 61.3 nM). Inhibits myeloma cell proliferation. Attenuates transcription of oncogenic MYC and suppresses key inflammatory genes. Exhibits efficacy in a range of oncology and immunoinf |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Bromodomain and extra-terminal motif (BET) inhibitor |
ALogP | 2.9 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488201413 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488201413 |
IUPAC Name | 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide |
INCHI | InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1 |
InChi Key | AAAQFGUYHFJNHI-SFHVURJKSA-N |
Canonical SMILES | CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C |
Isomeric SMILES | CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C |
PubChem CID | 46943432 |
Molecular Weight | 423.9 |
PubChem CID | 46943432 |
---|---|
CAS Registry No. | 1260907-17-2 |
ChEMBL Ligand | CHEMBL1232461 |
RCSB PDB Ligand | EAM |
PubChem SID | 488201413 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
D2317135 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317136 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317139 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317141 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317142 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317148 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317149 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317151 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317152 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317153 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317162 | Certificate of Analysis | Mar 09, 2023 | I166771 |
D2317228 | Certificate of Analysis | Mar 09, 2023 | I166771 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 42.39, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 42.39, Max Conc. mM: 100 |
---|
Pictogram(s) | GHS06, GHS08, GHS05 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed H373:Causes damage to organs through prolonged or repeated exposure H314:Causes severe skin burns and eye damage H318:Causes serious eye damage H360:May damage fertility or the unborn child |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P270:Do not eat, drink or smoke when using this product. P301+P330+P331:IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P363:Wash contaminated clothing before reuse. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P318:if exposed or concerned, get medical advice. P317:Get emergency medical help. P302+P361+P354:IF ON SKIN: Take off Immediately all contaminated clothing. Immediately rinse with water for several minutes. P316:Get emergency medical help immediately. P319:Get medical help if you feel unwell. |
1. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H et al.. (2010) Suppression of inflammation by a synthetic histone mimic.. Nature, 468 (7327): (1119-23). [PMID:21068722] |
2. Chung CW, Coste H, White JH, Mirguet O, Wilde J, Gosmini RL, Delves C, Magny SM, Woodward R, Hughes SA et al.. (2011) Discovery and characterization of small molecule inhibitors of the BET family bromodomains.. J Med Chem, 54 (11): (3827-38). [PMID:21568322] |
3. Chaidos A, Caputo V, Gouvedenou K, Liu B, Marigo I, Chaudhry MS, Rotolo A, Tough DF, Smithers NN, Bassil AK et al.. (2014) Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.. Blood, 123 (5): (697-705). [PMID:24335499] |
4. A-González N, Castrillo A. (2011) Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.. Biochim Biophys Acta, 1812 (8): (982-94). [PMID:21193033] |